• 사상체질의학회지
• /
• 제16권3호
• /
• pp.96-107
• /
• 2004

1. Objectives This study was carried out to investigate the effects of Gunyuljejo-tang on the $CCl_4$-induced Liver Damage in Rats. 2. Methods Sprague-Dawley rats were devided into 5 experimental groups : Normal, $NS+CCl_4$(Solid extract of $CCl_4$ injection group after Normal Saline feed), $GYJJT+CCl_4$(Solid extract of $CCl_4$ injection group after Gunyuljejo-tang feed), $CCl_4+NS$(Normal Saline feed group after $CCl_4$ injection), $CCl_4+GYJJT$(Solid extract of Gunyuljejo-tang feed group after $CCl_4$ injection). Biochemical assays for serum enzyme activities such as AST, ALT, ALP, BUN, Creatinine, Uric Acid, Total Protein, Albumin, Total Cholesterol, Triglyceride, Glucose, and mRNA Revelation of Cytochrome p450 and activities such as LPO, GSH, GST, Glutathione Reductase, Glutathione Peroxidase, SOD, Catalase, Hydroxyproline, and ${\beta}$-Glucuronidase were performed. 3. Results (1) $GYJJT+CCl_4$ showed lower revelation of Cytochrome p450. (2) $GYJJT+CCl_4$ showed higher GSH activity than $NS+CCl_4$, $CCl_4+GYJJT$ showed higher GSH activity than $CCl_4+NS$ injection significantly. (3) $GYJJT+CCl_4$ showed higher GST activity than $NS+CCl_4$. $CCl_4+GYJJT$ showed higher GST activity than $CCl_4+NS$ significantly. (4) $GYJJT+CCl_4$ showed higher Glutathione Peroxidase activity than $NS+CCl_4$, $CCl_4+GYJJT$ showed higher Glutathione Peroxidase activity than $CCl_4+NS$ significantly. (5) $CCl_4+GYJJT$ showed higher SOD activity than $CCl_4+NS$ significantly. (6) $CCl_4+GYJJT$ showed higher Catalase activity than $CCl_4+NS$ significantly. (7) $GYJJT+CCl_4$ showed lower Hydroxyproline than $NS+CCl_4$ significantly, $CCl_4+GYJJT$ showed higher Hydroxyproline than $CCl_4+NS$ significantly. (8) $GYJJT+CCl_4$ showed higher ${\beta}$-Glucuronidase activity than $NS+CCl_4$, $CCl_4+GYJJT$ showed higher ${\beta}$-Glucuronidase activity than $CCl_4+NS$ significantly. 4. Conclusions Gunyuljejo-tang has the recovering effects on the $CCl_4$-induced Liver Damage significantly.

• Childhood Kidney Diseases
• /
• 제14권1호
• /
• pp.51-61
• /
• 2010

목 적 : 최근 Chemokine (C-C motif) ligand-2 (CCL-2; also known as MCP-1)와 CCL-5 (also known as RANTES)가 다양한 염증성 및 비염증성 신질환과 연관성을 보인다는 연구결과들이 보고되고 있다. 이에 본 저자들은 CCL-2 및 CCL-5 유전자의 단일염기다형성(single nucleotide polymorphism; SNP)가 소아 IgA 신병증의 발생 및 임상양상과 어떠한 연관성을 보이는지 알아보기 위하여 본 연구를 시행하였다. 방 법 : 경희의료원 소아청소년과에서 학교 검뇨상 이상소견을 보여 전원된 환아 중 신생검을 통해 IgA 신병증으로 확진된 196명의 소아환아와 285명의 건강한 대조군을 대상으로 geneotyping을 통해 6 개의 SNP 대립 유전자 빈도를 조사하여 분석하였다. 또한, 단백뇨(>4 mg/$m^2$/hour), 병리 소견 상 족세포의 족돌기 융합과 병리학적 진행성 병변의 유무에 따라 환자군을 다시 세 개의 하위그룹으로 세분화하여 비교하였다. 결 과 : IgA 신병증 환아 및 대조군의 SNP 대립 유전자 빈도를 분석하였을 때, CCL-2 및 CCL-5 유전자 모두에서 질환의 발생과 연관성을 보이는 SNP는 발견되지 않았다. 두 개의 linkage disequilibrium block이 형성되었으나 하플로타입 분석에서는 유의한 하플로타입을 찾을 수 없었다. 또한, 환자의 하위그룹을 비교하였을 때에도 단백뇨, 병리 소견 상 족세포의 족돌기 융합과 병리학적 진행성 병변과 연관성을 보이는 SNP는 발견되지 않았다. 결 론 : 한국 소아 환자를 대상으로 시행한 본 연구에서 CCL-2 및 CCL-5유전자 다형성과 IgA 신병증의 임상병리 양상 간에 유의한 연관성은 없었다.

• 한국식품저장유통학회지
• /
• 제15권6호
• /
• pp.897-902
• /
• 2008

본 연구에서는 참취녹즙 : 당근즙액 : 인삼즙액의 혼합비율을 66.5 : 28.5 : 5로 혼합하여 제조한 혼합 참취녹즙이 사염화탄소 투여 흰쥐의 혈청지질에 미치는 영향을 조사하였다. 실험군은 정상식이군(NC군), 혼합 참취녹즙 식이군(BA군), 정상식이 4주 후 $CCl_4$를 투여하는 정상식이 사염화탄소 대조군($NC-CCl_4$군) 및 혼합 참취녹즙 식이 4주 후 $CCl_4$를 투여하는 혼합 참취녹즙 사염화탄소 대조군($BA-CCl_4$군)의 4군이었다. 식이섭취량은 모든 처리군 간에 차이가 없었으며, 증체량과 식이효율은 $NC-CCl_4$군만 크게 감소하였다. 체중 당 간의 중량비는 $NC-CCl_4$군은 NC군보다 크게 증가하였으나, $BA-CCl_4$군은 BA군과 유의적 차이가 없었다. 중성지질은 $NC-CCl_4$군만 유의적으로 증가하였고, $BA-CCl_4$군은 NC군이나 BA군과 차이가 없었다. 총 콜레스테롤 함량은 BA군만 낮았다. HDL-콜레스테롤 함량은 $NC-CCl_4$군은 유의적으로 감소하였으나, $BA-CCl_4$군은 NC군이나 BA군과 차이가 없었다. LDL-콜레스테롤 함량은 $NC-CCl_4$군(55.20 mg/dL)은 NC군(43.33 mg/dL)에 비해 유의적으로 증가하였으며, $BA-CCl_4$군(50.10 mg/dL)은 BA군(18.09 mg/dL)보다는 증가하였으나 $NC-CCl_4$군보다는 감소하는 경향이었다. Lipid peroxide 함량은 $NC-CCl_4$군은 NC군보다 크게 증가하였으나, $BA-CCl_4$군은 BA군과 유의적인 차이를 보이지 않았으며 $NC-CCl_4$군에 비해서는 크게 감소하였다. Glutathione 함량은 $NC-CCl_4$군이 $2.25\;{\mu}moles/g$로서 NC군과 BA군에 비해 크게 감소하였다. 그러나 $BA-CCl_4$군은 $2.63\;{\mu}moles/g$로서 BA군보다는 감소하였으나 NC군 수준으로 회복되었다.

• 한국정보처리학회:학술대회논문집
• /
• 한국정보처리학회 2009년도 춘계학술발표대회
• /
• pp.504-507
• /
• 2009

사용자 참여, 개방, 공유를 기반으로 하는 웹2.0 환경 하에서 보다 효율적이고 합법적으로 UCC(User Created Contents)가 제작, 공유, 유통되기 위한 저작권 시스템으로서, CCL(Creative Commons License)이 빠르게 확산되고 있다. 그러나, UCC에 CCL메타데이터를 직접 첨부하지 않는 기존의 CCL어노테이션 방식은 의도적으로 또는 비의도적으로 UCC와 CCL메타데이터가 분리될 수 있는 문제점을 가지고 있다. 그 결과, UCC로부터 분리되어진 저작권관련정보는 변경 또는 분실되어 추후에 저작권분쟁의 원인이 될 수 있다. 본 연구에서는 RDF와 XMP를 기반으로 CCL메타데이터를 이미지 컨텐츠에 직접 부착하는 방법을 제안하고 이를 지원하기 위한 어노테이션 지원도구(CCL-MASTer)를 개발하였다. 본 연구결과는, 기존의 어노테이션 기법의 문제점을 해결하고 다양하고 풍부한 CCL메타데이터의 효율적인 어노테이션을 가능케 하여 UCC 저작권분쟁 해결방안 및 UCC와 UCC관련 CCL메타데이터의 생성과 검색 등의 토대가 된다.

• 대한의생명과학회지
• /
• 제1권1호
• /
• pp.37-43
• /
• 1995

사염화탄소에의한 간손상시 $CCl_4$대사에 xanthine oxidase(XO)가 관련되는지를 규명하기위한 일환으로 allopurinol을 흰쥐 체중 Kg당 50mg을 전처치한다음 $CCl_4$를 투여한 후 처치하여 다음과 같은 결과를 얻었다. $CCl_4$투여로 인한 간조직의 postmitochondria 분획의 XO활성은 allopurinol을 전처치하므로서 현저히 감소되었으나 투석한 경우에는 오히려 증가되었으며 type D로부터 type O로의 전환율은 감소되었다. 또한, 투석한 간조직의 XO를 반응속도적인 측면에서 관찰해 볼 때 allopurinol을 전처치후 $CCl_4$투여군이 $CCl_4$단독투여 군보다 Vmax가 크게 나타났다. $CCl_4$투여로 인한 체중당 간무게의 증가율과 혈청 alanine aminotransferase활성증가율은 allopurinol을 전처치하므로서 저하되었다. 한편 $CCl_4$투여로 인한 간조직중 aniline hydroxylase및 glucose 6 phosphatase활성 감소율은 allopurinol을 전처치하므로서 저하되었다. 이상의 실험결과를 종합하여 볼때 실험동물에 $CCl_4$와 allopurinol을 병행 투여시 allopurinol이 사염화탄소에 의한 간손상을 억제시키는 현상은 XO와 사염화탄소 대사간에 관련성이 있음을 시사해주고 있다.

• 한국임상수의학회지
• /
• 제28권1호
• /
• pp.20-27
• /
• 2011

Hovenia dulcis Thunb (HDT) has been known folk medicine and has been used as therapeutic drug in the treatment of liver disease. Also it has been used as a detoxifying agents for alcoholic poisoning and promoting diuresis. However, there has not been any study on therapeutic effect of Hovenia dulcis extract on $CCl_4$ induced liver and kidney damage in rats. In this study, we report on therapeutic effects of Hovenia dulcis extract on $CCl_4$ induced liver and kidney damage in rats. Rats were divided into four groups of eighteen animals. Control group (DW) was administrated with distilled water 2.5 mL/kg per peritonial administration and then $CCl_4$ group (CCl) was administrated $CCl_4$ 2.5 mL/kg per peritonial administration, $CCl_4$+HDT extract group ($CCl_4$+HDT) was administrated HDT extrat (100 mg/kg) after $CCl_4$ 2.5 mL/kg administration, $CCl_4$+Silymarin group ($CCl_4$+Sily) was administrated Silymarin (50 mg/kg) after $CCl_4$ 2.5 mL/kg administration. The complete blood cell (CBC) count of RBC, WBC, PCV, Hb, MCH, MCV, MCHC and blood chemistry profile of AST, ALT, GGT, ALP, Total choloesterol, Tryglyceride, Total bilirubin, Amylase, Glucose, BUN, Creatinine, Lipase and pathologic changes were observed for 7 days after administration of D.W., $CCl_4$, $CCl_4$+HDT extract, $CCl_4$+Silymarin. The results are as follows : 1. RBC and PCV were significantly (p < 0.01) increased in all groups compared to D.W. but hemoglobin, MCH, MCV and MCHC were not showed significant difference during experimental periods. 2. AST, ALT, T-cholesterol, T-bilirubin, TG were significantly (p < 0.05) increased in all groups on day 3 compared to D.W. and were normal on day 7. 3. ALP was significantly (p < 0.05) decreased in $CCl_4$+HDT group on day 3 but Amylase was not showed significant difference during experimental periods. 4. BUN was significantly (p < 0.05) increased in $CCl_4$ group on day 7, but $CCl_4$+HDT group and $CCl_4$+Sily group were normal. Creatninie was significantly (p < 0.05) increased in $CCl_4$ group on day 3 and normal on day 7 but $CCl_4$+HDT group and $CCl_4$+Sily group were not showed significant difference during experimental periods.

• 한국식품영양과학회지
• /
• 제30권1호
• /
• pp.102-106
• /
• 2001

To investigate the effects of leek green juice on the damaged liver of $CCl_{4}$-treated rats, Sprague-Dawley male rats weighing about 100g, were divided into 4 groups ; control group (CON), leek green juice-administered group (LGJ), $CCl_{4}$-treated group (CCL) and leek green juice and $CCl_{4}$-treated group (LCL). After 6 weeks, the activities of sGPT and sGOT, and content of hepatic TBA-reactants, elevated by $CCl_{4}$ treatment, were markedly decreased by administering leek green juice, compared to CCL. It was also observed that activities of hepatic SOD and GSH-Px were elevated by $CCl_{4}$-treatment as compared to CON, but concomitant treatment of leek green juice and $CCl_{4}$ decreased those levels adjacent to CON, whereas catalase activity did not show significant decreasing effects compared to CCL. The hepatic content of glutathione, decreased by $CCl_{4}$, was more abundantly increased by leek green juice administration than by CCL. These results suggest that leek green juice is believed to b a possible protective effect for the carbon tetrachloride-induced hepatotoxicity in rat liver.

• 한국식품영양과학회지
• /
• 제27권3호
• /
• pp.531-536
• /
• 1998

To investigate effects of Angelica keiskei Koidz green juice on the liver damage of CCl4-treated tats, Sprague-Dawley male rats weighing 80~100g were divided into 4 groups of control group(CON), Angelica keiskei Koidz green juice-treated group(ANJ), CCl4-treated group(CCL) and Angelica keiskei Kodiz green juice and CCl4-treated group(ACL). Each group was sacrified after feeding for 4 weeks and examined the activities of transminase (sGOT, sGPT), superoxide dismutase (SOD), catalase and glutathione peroxidase(GSH-Px), and contents of lipid peroxide and glutathione in liver. The activities of sGOT and sGPT, and content of lipid peroxide after CCl4 treatment were markedly increased, compared to CON, but those levels were significantly decreased by the pretreatment of Angelica keiskei Koidz green juice as compared to CCL. The activities of SOD, catalase and GSH-Px were elevated by CCl4-treatment as compared to control group, and concomitant treatment of Angelical keiskei Koidz and CCl4 decreased those levels significantly except the activity of catalase. The hepatic content of glutathione was decreased by CCl4 and increased more abundant by Angelica keiskei Koidz administration than CCl4 treated group. These results suggest that Angelica keiskei Koidz green juice is believed to have a possible protective effect for the carbon tetrachloride-induced hepatotoxicity in rats.

• The Korean Journal of Physiology and Pharmacology
• /
• 제13권5호
• /
• pp.385-392
• /
• 2009

Angiotensin II (Ang II) plays an important role in vascular hypertension. The role of the chemokine CCL5 on Ang II-induced activities in vascular smooth muscle cells (VSMCs) has not been studied. In this study, we elucidated the effect of CCL5 on Ang II-induced 12-lipoxygenase (LO) expression and cell proliferation in spontaneously hypertensive rats (SHR) VSMCs. CCL5 decreased Ang II-induced 12-LO mRNA expression and protein production, and it increased Ang II type 2 ($AT_2$) receptor expression in SHR VSMCs. The inhibitory effect of CCL5 on Ang II-induced 12-LO mRNA expression was mediated through the $AT_2$ receptor. Although treatment of CCL5 alone induced SHR VSMCs proliferation, CCL5 inhibited Ang II-induced VSMCs proliferation and PD123,319, an $AT_2$ receptor antagonist, blocked the inhibitory effect of CCL5 on Ang II-induced VSMCs proliferation. Phosphorylation of p38 was detected in VSMCs treated with Ang II or CCL5 alone. But, decrease of p38 phosphorylation was detected in VSMCs treated with Ang II and CCL5 simultaneously (Ang II/CCL5) and PD123,319 increased p38 phosphorylation in VSMCs treated with Ang II/CCL5. Therefore, these results suggest that the inhibitory effect of CCL5 on Ang II-induced VSMCs proliferation is mediated by the $AT_2$ receptor via p38 inactivation, and CCL5 may play a beneficial role in Ang II-induced vascular hypertension.

• IMMUNE NETWORK
• /
• 제21권3호
• /
• pp.23.1-23.16
• /
• 2021

Chemokines are key factors that influence the migration and maintenance of relevant immune cells into an infected tissue or a tumor microenvironment. Therefore, it is believed that the controlled administration of chemokines in the tumor microenvironment may be an effective immunotherapy against cancer. Previous studies have shown that CCL3, also known as macrophage inflammatory protein 1-alpha, facilitates the recruitment of dendritic cells (DCs) for the presentation of tumor Ags and promotes T cell activation. Here, we investigated the role of CCL3 in regulating the tumor microenvironment using a syngeneic mouse tumor model. We observed that MC38 tumors overexpressing CCL3 (CCL3-OE) showed rapid regression compared with the wild type MC38 tumors. Additionally, these CCL3-OE tumors showed an increase in the proliferative and functional tumor-infiltrating T cells. Furthermore, PD-1 immune checkpoint blockade accelerated tumor regression in the CCL3-OE tumor microenvironment. Next, we generated a modified CCL3 protein for pre-clinical use by fusing recombinant CCL3 (rCCL3) with a non-cytolytic hybrid Fc (HyFc). Administering a controlled dose of rCCL3-HyFc via subcutaneous injections near tumors was effective in tumor regression and improved survival along with activated myeloid cells and augmented T cell responses. Furthermore, combination therapy of rCCL3-HyFc with PD-1 blockade exhibited prominent effect to tumor regression. Collectively, our findings demonstrate that appropriate concentrations of CCL3 in the tumor microenvironment would be an effective adjuvant to promote anti-tumor immune responses, and suggest that administering a long-lasting form of CCL3 in combination with PD-1 blockers can have clinical applications in cancer immunotherapy.